BMRN
WATCH BioMarin Pharmaceutical Inc. · US
—
—
Prices as of close 2026-07-28
Profitable rare-disease biotech with steadier fundamentals and room for rerating on execution.
Buy signals
- ▸Morningstar includes it among undervalued biotech stocks.
Related Biotech picks
AI-generated research for educational purposes only — not investment advice. Prices are end-of-day.